Asarina Pharma ApS: Financial statements 2022
CVR: 38495712
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Asarina Pharma ApS (CVR 38495712) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -508,850 and a net result of DKK -9,822,821 compared with DKK -24,704,716 the year before. Equity in the 2022 report amounted to DKK 42,708,929. The solvency ratio was 97.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -508,850
- Profit/Loss
- DKK -9,822,821
- Equity
- DKK 42,708,929
- Total Assets
- DKK 43,649,479
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -509 t. | -9.8 mio. | 42.7 mio. | 1 |
| 2021 | - | -887 t. | -24.7 mio. | 49 mio. | 1 |
| 2020 | - | -1.9 mio. | -51.5 mio. | 44.1 mio. | 2 |
| 2019 | - | -1.4 mio. | -52.4 mio. | 51.1 mio. | 3 |
| 2018 | - | -891.9 mio. | -31.3 mia. | 12.1 mia. | - |
Official annual report
Keep an eye on Asarina Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Asarina Pharma ApS has published its annual report for 2021. Gross profit came to DKK -887,274, and the net result was DKK -24,704,716.
About Asarina Pharma ApS
Asarina Pharma ApS was a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2017. The company has been dissolved on 30 June 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Asarina Danmark ApS. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK -365,453 and a net result of DKK -1,333,232 compared with DKK -42,903,193 the year before. Equity in the 2024 report amounted to DKK -107,343.